Lori Coolidge
Chief Technology Officer
Professional Overview
Lori Coolidge is an accomplished Chief Technology Officer with extensive expertise in driving technological innovation and transformation within the biotechnology industry. As the CTO of NeoGenomics, she is responsible for spearheading the company's technological strategy, overseeing its digital infrastructure, and leveraging cutting-edge technologies to enhance the organization's genomic testing capabilities.
Experience Summary
Current Role
Lori has served as the Chief Technology Officer of NeoGenomics, a leading provider of cancer-focused genetic testing and information services, since June 2019. In this role, she is responsible for aligning the organization's technology roadmap with its strategic business objectives, while ensuring the seamless integration and optimization of its complex genomic data systems. Under her leadership, NeoGenomics has implemented several transformative initiatives, including the development of a robust cloud-based platform that has significantly improved data management, analysis, and reporting capabilities.
Career Progression
Prior to joining NeoGenomics, Lori held various technology leadership positions within the biotechnology industry. She served as the Vice President of Information Technology at Illumina, a prominent global leader in DNA sequencing and array-based technologies, where she played a pivotal role in scaling the company's digital infrastructure to support its rapid growth. Lori's earlier career included roles as a Senior Software Engineer at Qiagen, a global provider of molecular diagnostics and sample preparation solutions, and as a Research Scientist at Roche Diagnostics, where she contributed to the development of innovative molecular biology-based assays.
Academic Background
Lori holds a Bachelor of Science degree in Bioinformatics from the University of California, San Diego, and a Master of Science degree in Computer Science from the University of Illinois at Urbana-Champaign. Her academic achievements include several published research papers and presentations at industry-leading conferences.
Areas of Expertise
- Biotechnology and genomics industry expertise
- Digital transformation and enterprise IT strategy
- Data management and analytics for complex genomic data
- Software engineering and application development
- Operational excellence and continuous process improvement
- Cross-functional collaboration and team leadership
Professional Impact
Throughout her career, Lori has been recognized for her ability to drive technological innovation and deliver measurable business impact. At NeoGenomics, she has spearheaded the development of a cutting-edge cloud-based platform that has enhanced the company's genomic testing capabilities, resulting in a 25% increase in test throughput and a 30% reduction in turnaround time. Her contributions have been instrumental in positioning NeoGenomics as a leader in the precision oncology market.
Conclusion
Lori Coolidge is a seasoned technology executive with a proven track record of driving digital transformation and leveraging emerging technologies to solve complex challenges in the biotechnology industry. Her technical expertise, strategic vision, and commitment to operational excellence make her a valuable asset to NeoGenomics as the company continues to redefine the standard of care in cancer diagnostics and patient care.
